Skip to main content
All lobbying filings

VENABLE LLP

Lobbying for AMERICAN ASSOCIATION OF PSYCHIATRIC PHARMACISTS · Non-Profit, National Membership Organization for Psychiatric Pharmacists

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · Nebraska · House · Senate · $30,000.00 income · posted Jul 20, 2026

Official filing document

 Lobbying activity 1
Health Issues

Increasing access to mental health and substance use treatment, including via telehealth; Mental health & substance use disorder workforce; Federal funding for mental health and substance use programs, research and training; Preventing and reducing suicide; Medicare Part B coverage of pharmacist provided patient care services; Maintaining access to vaccines for children and adults; Medicare quality measures for and staffing of long-term care and skilled nursing facilities; Increase access to methadone for treatment of substance use; Maintain the six protected drug classes in Medicare Part D.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem